Norcantharidin analogues: a patent review (2006 – 2010)

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.11, 2011-11, pp. : 1743-1753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antifolate agents: a patent review (2006 – 2010)

By Wright Dennis L Anderson Amy C

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1293-1308

Informa Healthcare

Access to resources Recommend Favorite

Toll-like receptor modulators: a patent review (2006 –– 2010)

By Basith Shaherin Manavalan Balachandran Lee Gwang Kim Sang Geon Choi Sangdun

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 6, 2011-06 ,pp. : 927-944

Informa Healthcare

Access to resources Recommend Favorite

Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 –– 2010)

By Lu Xiaoyun Huang Kun You Qidong

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 1007-1022

Informa Healthcare

Access to resources Recommend Favorite

AMP-activated protein kinase modulators: a patent review (2006 –– 2010)

By Yun Hee Ha Joohun

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 983-1005

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl pyrophosphate synthase modulators: a patent review (2006 – 2010)

By Sun Shuting McKenna Charles E

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1433-1451

Informa Healthcare

Access to resources Recommend Favorite